Ischemic stroke remains one of the leading causes of long-term disability worldwide depriving patients of their quality of life and physical independence. The root cause of this loss of motor movement stems from the disruption of neuronal connections in the infarct site. Limited spontaneous neural re-wiring post stroke does provide limited functional recovery but more than two thirds of ischemic stroke patients suffer from long term disability for the remainder of their lives. Here we explore the codelivery of synaptonogenic proteins with an angiogenic biomaterial to promote synapse formation in a mouse model of ischemic stroke. The angiogenic biomaterial is based on microporous annealed particle (MAP) scaffolds containing previously reported pro-angiogenic clustered vascular endothelial growth factor (CLUVENA) heparin nanoparticles. To this material pro-synaptogenic protein thrombospondin-1 (TSP-1) were added as either soluble or in clustered nanoparticle form. Co-delivery of TSP-1 with CLUVENA within MAP scaffolds led to enhanced synapse formation in and around the infarct despite a reduction in axonal sprouting when compared to CLUVENA delivery alone. TSP-1 treatment also resulted in increased glial scar thickness and astrocytic coverage in the peri-infarct region potentially contributing to limited axonal integration. Overall these findings highlight the capacity of TSP-1 to modulate the synaptic and glial landscape post-stroke.
